GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paxman AB (FRA:B0F) » Definitions » Debt-to-Revenue

Paxman AB (FRA:B0F) Debt-to-Revenue : 0.07 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Paxman AB Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Paxman AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.31 Mil. Paxman AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.21 Mil. Paxman AB's annualized Revenue for the quarter that ended in Mar. 2024 was €20.72 Mil. Paxman AB's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.07.


Paxman AB Debt-to-Revenue Historical Data

The historical data trend for Paxman AB's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paxman AB Debt-to-Revenue Chart

Paxman AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial 0.37 0.62 0.18 0.12 0.07

Paxman AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.08 0.08 0.06 0.07

Competitive Comparison of Paxman AB's Debt-to-Revenue

For the Medical Devices subindustry, Paxman AB's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paxman AB's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Paxman AB's Debt-to-Revenue falls into.



Paxman AB Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Paxman AB's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.987 + 0.226) / 18.784
=0.06

Paxman AB's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.311 + 0.208) / 20.72
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Paxman AB Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Paxman AB's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Paxman AB (FRA:B0F) Business Description

Traded in Other Exchanges
Address
Pirgatan 13, Karlshamn, SWE, SE-374 35
Paxman AB is a Sweden based company engages in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.

Paxman AB (FRA:B0F) Headlines

No Headlines